@article {Salcher-Konrad2020.06.09.20125237, author = {Maximilian Salcher-Konrad and Arnoupe Jhass and Huseyin Naci and Marselia Tan and Yousef El-Tawil and Adelina Comas-Herrera}, title = {COVID-19 related mortality and spread of disease in long-term care: a living systematic review of emerging evidence}, elocation-id = {2020.06.09.20125237}, year = {2020}, doi = {10.1101/2020.06.09.20125237}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Policy responses to mitigate the impact of the COVID-19 pandemic on long-term care (LTC) require robust and timely evidence on mortality and spread of the disease in these settings. The aim of this living systematic review is to synthesise early international evidence on mortality rates and incidence of COVID-19 among people who use and provide LTC.Methods We report findings of a living systematic review (CRD42020183557), including studies identified through database searches up to 26 June 2020. We searched seven databases (MEDLINE; Embase; CINAHL Plus; Web of Science; Global Health; WHO COVID-19 Research Database; medRxiv) to identify all studies reporting primary data on COVID-19 related mortality and incidence of disease among LTC users and staff. We excluded studies not focusing on LTC. Included studies were critically appraised and results on number of deaths and COVID-19 related mortality rates, case fatality rates, and excess deaths (co-primary outcomes), as well as incidence of disease, hospitalisations, and ICU admissions were synthesised narratively.Findings A total of 54 study reports for 49 unique primary studies or outbreak reports were included. Outbreak investigations in LTC facilities found COVID-19 incidence rates of between 0.0\% and 71.7\% among residents and between 0.4\% and 64.0\% among staff at affected facilities. Mortality rates varied from 0.0\% to 17.1\% of all residents at outbreak facilities, with case fatality rates between 0.0\% and 33.7\%. In included studies of outbreaks, no LTC staff members had died.Studies of wider LTC populations found that between 0.4\% and 40.8\% of users, and between 4.0\% and 23.8\% of staff were infected, although the generalisability of these studies is limited.There was limited information on the impact of COVID-19 on LTC in the community.Interpretation Long-term care users have been particularly vulnerable to the COVID-19 pandemic. However, we found wide variation in spread of disease and mortality rates between outbreaks at individual LTC facilities. Further research into the factors determining successful prevention and containment of COVID-19 outbreaks is needed to protect long-term care users and staff.Funding This work was partially conducted as part of the {\textquotedblleft}Strengthening responses to dementia in developing countries{\textquotedblright} (STRiDE) project, supported by the UK Research and Innovation{\textquoteright}s Global Challenges Research Fund (ES/P010938/1). The funders had no role in the design and execution of this study, interpretation of its results, and decision to submit this work to be published.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=183557 Funding StatementFunding: This work was partially conducted as part of the "Strengthening responses to dementia in developing countries" (STRiDE) project, supported by the UK Research and Innovation{\textquoteright}s Global Challenges Research Fund (ES/P010938/1). The funders had no role in the design and execution of this study, interpretation of its results, and decision to submit this work to be published.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is a systematic review using published summary-level data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data are presented in the manuscript. Additional data available from authors upon request.}, URL = {https://www.medrxiv.org/content/early/2020/08/01/2020.06.09.20125237}, eprint = {https://www.medrxiv.org/content/early/2020/08/01/2020.06.09.20125237.full.pdf}, journal = {medRxiv} }